Trxade Group Inc. (TRXD) Offers Innovative Web-Based Pharmaceutical Purchasing Platform
- Trxade Group helps independent pharmacies identify the best supplier prices for prescription drugs
- The company’s trading platform allows independent pharmacies to stay informed about up-to-the-minute pricing on a cost-effective basis
- Trxade provides its services to pharmacies and consumers
An integrated pharmaceutical services company, Trxade Group Inc. (OTCQB: TRXD) offers an S2P (Supplier to Pharmacy) market platform. The platform helps independent pharmacies operating nationwide to identify the best available supplier prices for prescription drugs. Trxade is the largest online pharmaceutical marketplace platform in the United States. Per corporate data, the platform has been shown to reduce a pharmacy’s total yearly purchase costs by 7-10 percent (http://nnw.fm/Cdxj4).
Headquartered out of Land O’ Lakes, Florida, Trxade Group brings pharmaceutical buyers and sellers together. The company’s strategy is to use price analytics and supplier competition to pass considerable advantages directly to its members. Its focus is on the best pricing and availability of generic and branded pharmaceuticals. Trxade’s platform maintains a wide-ranging generic and branded pharmaceutical portfolio that is accessible to community pharmacies across the nation.
The Trxade platform allows a third of the approximately 24,000 independent pharmacies in the United States to keep abreast of up-to-the-minute pricing on a cost-effective basis. Pharmacies pay no membership or transaction fees for using the platform, which offers access to numerous supplier sources. In addition, the platform has an easy layout for price comparison and purchasing. Trxade Exchange also opens and expands the distribution channel to retail and community pharmacies (http://nnw.fm/1xjHk).
Trxade Group earns a transaction fee from sellers on the trading platform. The company charges 5 percent on each transaction value for generic drugs and 0.25 percent for branded drugs. Trxade Group also focuses on the consumer side of the pharmaceutical industry, offering drug price transparency and efficient buying. The company also facilitates delivery of drugs directly to independent pharmacists and consumers, operating a full-service mail order pharmacy for U.S. consumers. Furthermore, the Trxade Group Delivmeds mobile app enables same-day home delivery of dispensed prescriptions.
The company also offers RX Guru (http://nnw.fm/FnJS9). This price-prediction model integrates product shortage insight into pharmacy acquisition benchmarks to determine trends and pricing variances that could result in major purchasing opportunities. Fundamentally, RX Guru provides its members with an opportunity to benefit from real price-purchasing opportunities that are often concealed from the rest of the industry.
With its proprietary technology and extensive database, Trxade Group is poised to further penetrate its target market of independent pharmacies and their $93 billion of annual purchases. For investors, the company offers the potential for significant returns due to its low-risk, high-return business model. With a strategy focused on adding new industry sectors, such as hospitals, veterinarians and long-term care, Trxade Group continues to advance its initiatives for organic growth.
For more information, visit the company’s website at www.TrxadeGroup.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Trxade Group helps independent pharmacies identify the best supplier prices for prescription drugs
- The company’s trading platform allows independent pharmacies to stay informed about up-to-the-minute pricing on a cost-effective basis
- Trxade provides its services to pharmacies and consumers
An integrated pharmaceutical services company, Trxade Group Inc. (OTCQB: TRXD) offers an S2P (Supplier to Pharmacy) market platform. The platform helps independent pharmacies operating nationwide to identify the best available supplier prices for prescription drugs. Trxade is the largest online pharmaceutical marketplace platform in the United States. Per corporate data, the platform has been shown to reduce a pharmacy’s total yearly purchase costs by 7-10 percent (http://nnw.fm/Cdxj4).
Headquartered out of Land O’ Lakes, Florida, Trxade Group brings pharmaceutical buyers and sellers together. The company’s strategy is to use price analytics and supplier competition to pass considerable advantages directly to its members. Its focus is on the best pricing and availability of generic and branded pharmaceuticals. Trxade’s platform maintains a wide-ranging generic and branded pharmaceutical portfolio that is accessible to community pharmacies across the nation.
The Trxade platform allows a third of the approximately 24,000 independent pharmacies in the United States to keep abreast of up-to-the-minute pricing on a cost-effective basis. Pharmacies pay no membership or transaction fees for using the platform, which offers access to numerous supplier sources. In addition, the platform has an easy layout for price comparison and purchasing. Trxade Exchange also opens and expands the distribution channel to retail and community pharmacies (http://nnw.fm/1xjHk).
Trxade Group earns a transaction fee from sellers on the trading platform. The company charges 5 percent on each transaction value for generic drugs and 0.25 percent for branded drugs. Trxade Group also focuses on the consumer side of the pharmaceutical industry, offering drug price transparency and efficient buying. The company also facilitates delivery of drugs directly to independent pharmacists and consumers, operating a full-service mail order pharmacy for U.S. consumers. Furthermore, the Trxade Group Delivmeds mobile app enables same-day home delivery of dispensed prescriptions.
The company also offers RX Guru (http://nnw.fm/FnJS9). This price-prediction model integrates product shortage insight into pharmacy acquisition benchmarks to determine trends and pricing variances that could result in major purchasing opportunities. Fundamentally, RX Guru provides its members with an opportunity to benefit from real price-purchasing opportunities that are often concealed from the rest of the industry.
With its proprietary technology and extensive database, Trxade Group is poised to further penetrate its target market of independent pharmacies and their $93 billion of annual purchases. For investors, the company offers the potential for significant returns due to its low-risk, high-return business model. With a strategy focused on adding new industry sectors, such as hospitals, veterinarians and long-term care, Trxade Group continues to advance its initiatives for organic growth.
For more information, visit the company’s website at www.TrxadeGroup.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
